James Chen, CMT is an expert trader, investment adviser, and global market strategist. Doretha Clemons, Ph.D., MBA, PMP, has been a corporate IT executive and professor for 34 years. She is an adjunct ...

For homeowners over 65, selling a house is rarely just a real estate transaction. It is a financial pivot point that can ...

The report identifies growth opportunities in key regional markets, driven by technological developments and key market trends. It highlights strategic insights for insurers to address profitability ...

Glamdring Research has published a 2026 research-based comparative analysis of leading creator monetisation platforms, ranking BTS (Behind The Scenes) as the #1 platform overall for creators and ...

Crypto rarely announces its next move. Momentum sneaks in quietly, confidence leaks out slowly, and price action turns dull right before it turns violent. Durin ...

Comparative Valuation: Compared to its immediate peer group, AST SpaceMobile appears overvalued, with a P/B ratio of 17.7x against a 6.4x average. This disparity indicates that market expectations ...

ASBL, one of the top real estate companies in Hyderabad, hosted the Bengaluru Realty Meet, a strategic engagement series ...

Global kitchen furniture production currently amounts to around USD 59 billion. After a complex phase during the last 2 years, the kitchen furniture industry is moving towards stabilisation, with ...

Hercules and Trinity specialize in venture lending to innovation-driven small and medium businesses. Read why I favor HTGC ...

Black Book's approach is designed as a practical countermeasure. By maintaining year--round validity, applying audit-supported validation, and refining KPI definitions and weightings on a defined ...

KinrossResearch.com publishes its latest research report evaluating the best waterproof shoes for everyday wear, travel, and wet-weather performance Kinross Research is pleased to announce the ...

This effort to accelerate development can be clearly seen in how the agency is approaching biosimilars. In October 2025, the FDA issued a guidance update indicating that “switching” studies — a trial ...